Convertible Preferred Stock and Stockholders' Equity (Deficit) - Summary of the Status of the Options Issued Under the Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Options Outstanding, Balance at December 31, 2021	6,591,727
Authorized increase in plan shares	0
Options Outstanding, Granted	1,258,140
Options Outstanding, Exercised (including early)	(295,764)
Options Outstanding, Balance at March 31, 2022	7,554,103	6,591,727
Options Outstanding, Vested and expected to vest as of March 31, 2022	7,554,103
Options Outstanding, Vested and exercisable at March 31, 2022	1,563,412
Weighted average exercise price per share, Balance at December 31, 2021	$ 8.04
Weighted average exercise price per share, Granted	17.48
Weighted average exercise price per share, Exercised (including early)	0.94
Weighted average exercise price per share, Balance at March 31, 2022	9.89	$ 8.04
Weighted average exercise price per share, Vested and expected to vest as of March 31, 2022	9.89
Weighted average exercise price per share, Vested and exercisable at March 31, 2022	$ 5.99
Weighted average remaining contractual term (Years)	9 years 2 months 8 days	9 years 3 months 3 days
Weighted average remaining contractual term, Vested and expected to vest as of March 31, 2022	9 years 2 months 8 days
Weighted average remaining contractual term, Vested and exercisable at March 31, 2022	9 years
Aggregate intrinsic value, Exercised (including early)	$ 4,290,213
Aggregate intrinsic value, Balance at March 31, 2022	11,365,470
Vested and expected to vest as of March 31, 2022	11,365,470
Aggregate intrinsic value, Vested and exercisable at March 31, 2022	$ 3,058,199